Abstract CT058: TROPION-PanTumor03: Phase 2, multicenter study of datopotamab deruxtecan (Dato-DXd) as monotherapy and in combination with anticancer agents in patients (pts) with advanced/metastatic solid tumorsFunda Meric‐Bernstam, Ana Oaknin, Joshua M. Lang et al.|Cancer Research|2023Cited by 1